pathophysiology remains uncertain. 1,3 However, clinical improvement with immunosuppressive therapy during the active phase of the disease strongly suggests an underlying immunologic-mediated process. 1,3 Neurological symptoms (seizures, headache and facial pain) affect 15-20% of patients and brain involvement can be better evaluated with magnetic resonance imaging. 1